112 related articles for article (PubMed ID: 1964538)
1. Pituitary-adrenal responses to ovine corticotropin-releasing factor in polycystic ovary syndrome and in other hyperandrogenic patients.
Carmina E; Lobo RA
Gynecol Endocrinol; 1990 Dec; 4(4):225-32. PubMed ID: 1964538
[TBL] [Abstract][Full Text] [Related]
2. Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism.
Rittmaster RS; Thompson DL
J Clin Endocrinol Metab; 1990 Apr; 70(4):1096-102. PubMed ID: 2156885
[TBL] [Abstract][Full Text] [Related]
3. Circulating levels of plasma adrenocorticotropin in polycystic ovary disease.
Chang RJ; Mandel FP; Wolfsen AR; Judd HL
J Clin Endocrinol Metab; 1982 Jun; 54(6):1265-7. PubMed ID: 6281296
[TBL] [Abstract][Full Text] [Related]
4. Effects of flutamide on pituitary and adrenal responsiveness to corticotrophin releasing factor (CRF).
De Leo V; la Marca A; Lanzetta D; Cariello PL; D'Antona D; Morgante G
Clin Endocrinol (Oxf); 1998 Jul; 49(1):85-9. PubMed ID: 9797851
[TBL] [Abstract][Full Text] [Related]
5. Increased adrenal steroid secretion in response to CRF in women with hypothalamic amenorrhea.
Genazzani AD; Bersi C; Luisi S; Fruzzetti F; Malavasi B; Luisi M; Petraglia F; Genazzani AR
J Steroid Biochem Mol Biol; 2001 Sep; 78(3):247-52. PubMed ID: 11595505
[TBL] [Abstract][Full Text] [Related]
6. Gonadotrophin and gonadal steroid response to a single dose of a long-acting agonist of gonadotrophin-releasing hormone in ovulatory and anovulatory women with polycystic ovary syndrome.
White D; Leigh A; Wilson C; Donaldson A; Franks S
Clin Endocrinol (Oxf); 1995 May; 42(5):475-81. PubMed ID: 7621565
[TBL] [Abstract][Full Text] [Related]
7. Adrenal and ovarian steroid hormone responses to gonadotropin-releasing hormone agonist treatment in polycystic ovary syndrome.
Gonzalez F; Hatala DA; Speroff L
Am J Obstet Gynecol; 1991 Sep; 165(3):535-45. PubMed ID: 1832519
[TBL] [Abstract][Full Text] [Related]
8. Evidence for the importance of peripheral tissue events in the development of hirsutism in polycystic ovary syndrome.
Lobo RA; Goebelsmann U; Horton R
J Clin Endocrinol Metab; 1983 Aug; 57(2):393-7. PubMed ID: 6223045
[TBL] [Abstract][Full Text] [Related]
9. Pituitary and adrenal response to ovine corticotropin-releasing hormone in women with polycystic ovarian syndrome.
Mongioì A; Macchi M; Vicari E; Fornito MC; Calogero AE; Riccioli C; Minacapilli G; Moncada ML; D'Agata R
J Endocrinol Invest; 1988 Oct; 11(9):637-40. PubMed ID: 3265424
[TBL] [Abstract][Full Text] [Related]
10. Elevated bioactive luteinizing hormone in women with the polycystic ovary syndrome.
Lobo RA; Kletzky OA; Campeau JD; diZerega GS
Fertil Steril; 1983 May; 39(5):674-8. PubMed ID: 6220924
[TBL] [Abstract][Full Text] [Related]
11. Pituitary and ovarian responses to LHRH stimulation in women with clinical features of the polycystic ovary syndrome.
Heineman MJ; Thomas CM; Doesburg WH; Rolland R
Eur J Obstet Gynecol Reprod Biol; 1984 Jun; 17(4):273-84. PubMed ID: 6430731
[TBL] [Abstract][Full Text] [Related]
12. Adrenal androgen excess in the polycystic ovary syndrome: sensitivity and responsivity of the hypothalamic-pituitary-adrenal axis.
Azziz R; Black V; Hines GA; Fox LM; Boots LR
J Clin Endocrinol Metab; 1998 Jul; 83(7):2317-23. PubMed ID: 9661602
[TBL] [Abstract][Full Text] [Related]
13. Low serum dehydroepiandrosterone sulfate in women with primary Sjögren's syndrome as an isolated sign of impaired HPA axis function.
Valtysdóttir ST; Wide L; Hällgren R
J Rheumatol; 2001 Jun; 28(6):1259-65. PubMed ID: 11409117
[TBL] [Abstract][Full Text] [Related]
14. Mild adrenal and ovarian steroidogenic abnormalities in hirsute women without hyperandrogenemia: does idiopathic hirsutism exist?
Escobar-Morreale HF; Serrano-Gotarredona J; García-Robles R; Sancho J; Varela C
Metabolism; 1997 Aug; 46(8):902-7. PubMed ID: 9258272
[TBL] [Abstract][Full Text] [Related]
15. The impact of estrogen on adrenal androgen sensitivity and secretion in polycystic ovary syndrome.
Ditkoff EC; Fruzzetti F; Chang L; Stancyzk FZ; Lobo RA
J Clin Endocrinol Metab; 1995 Feb; 80(2):603-7. PubMed ID: 7852527
[TBL] [Abstract][Full Text] [Related]
16. Adrenal hyperresponsiveness to ACTH stimulation in women with polycystic ovary syndrome: an adrenarchal type of response.
Anapliotou MG; Syrigos K; Papanicolaou T; Panayiotakopoulos G; Kalos A; Batrinos ML
Int J Fertil; 1990; 35(4):230-9. PubMed ID: 1977716
[TBL] [Abstract][Full Text] [Related]
17. Increased circulating levels of immunoreactive beta-endorphin in polycystic ovary syndrome is not caused by increased pituitary secretion.
Carmina E; Ditkoff EC; Malizia G; Vijod AG; Janni A; Lobo RA
Am J Obstet Gynecol; 1992 Dec; 167(6):1819-24. PubMed ID: 1471704
[TBL] [Abstract][Full Text] [Related]
18. The hypothalamo-pituitary-adrenal axis across the normal menstrual cycle and in polycystic ovary syndrome.
Stewart PM; Penn R; Holder R; Parton A; Ratcliffe JG; London DR
Clin Endocrinol (Oxf); 1993 Apr; 38(4):387-91. PubMed ID: 8391404
[TBL] [Abstract][Full Text] [Related]
19. Early polycystic ovary-like syndrome in girls with central precocious puberty and exaggerated adrenal response.
Lazar L; Kauli R; Bruchis C; Nordenberg J; Galatzer A; Pertzelan A
Eur J Endocrinol; 1995 Oct; 133(4):403-6. PubMed ID: 7581961
[TBL] [Abstract][Full Text] [Related]
20. Prolactin levels in the polycystic ovary syndrome.
Milewicz A
J Reprod Med; 1984 Mar; 29(3):193-6. PubMed ID: 6233421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
